References
Thurn J (1998) Human parvovirus B19: historical and clinical review. Rev Infect Dis 10:1005–1011
Kerr JR (2000) Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis 59:672–683
Bousvaros A, Sundel R, Thorne GM et al. (1998) Parvovirus B19-associated interstitial lung disease, hepatitis, and myositis. Pediatr Pulmonol 26:365–369
Kalish RA, Knopf AN, Gary GW, Canoso JJ (1992) Lupus-like presentation of human parvovirus B19 infection. J Rheumatol 19:169–171
Finkel TH, Torok TJ, Ferguson PJ et al. (1994) Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet 343:1255–1258
Ozawa K, Ayub J, Hao YS, Kurtzman G, Shimada T, Young N (1987) Novel transcription map for the B19 (human) pathogenic parvovirus. J Virol 61:2395–2406
Moffatt S, Tanaka N, Tada K et al. (1996) A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J Virol 70:8485–8491
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ichinose, K., Migita, K., Sekita, T. et al. Parvovirus B19 infection and myofasciitis. Clin Rheumatol 23, 184–185 (2004). https://doi.org/10.1007/s10067-003-0837-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-003-0837-8